INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 257 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,154,170 | -52.6% | 187,331 | -48.9% | 0.01% | -50.0% |
| Q2 2023 | $15,088,293 | -27.0% | 366,844 | +1.9% | 0.01% | -36.8% |
| Q1 2023 | $20,672,538 | +2.6% | 360,086 | +0.2% | 0.02% | -5.0% |
| Q4 2022 | $20,146,792 | +39.7% | 359,315 | +5.6% | 0.02% | +42.9% |
| Q3 2022 | $14,418,000 | -3.1% | 340,365 | +23.6% | 0.01% | -6.7% |
| Q2 2022 | $14,880,000 | +12.4% | 275,402 | +33.6% | 0.02% | +50.0% |
| Q1 2022 | $13,243,000 | -4.7% | 206,087 | -0.6% | 0.01% | +11.1% |
| Q4 2021 | $13,889,000 | +35.2% | 207,329 | +38.3% | 0.01% | +28.6% |
| Q3 2021 | $10,270,000 | -53.3% | 149,965 | -53.5% | 0.01% | -53.3% |
| Q2 2021 | $22,008,000 | -18.7% | 322,510 | -17.7% | 0.02% | -25.0% |
| Q1 2021 | $27,070,000 | +2.7% | 391,803 | -3.5% | 0.02% | +5.3% |
| Q4 2020 | $26,365,000 | +56.1% | 406,118 | +13.5% | 0.02% | +35.7% |
| Q3 2020 | $16,895,000 | -24.0% | 357,796 | -24.4% | 0.01% | -30.0% |
| Q2 2020 | $22,231,000 | -25.8% | 473,103 | -29.4% | 0.02% | -44.4% |
| Q1 2020 | $29,942,000 | -35.0% | 670,284 | -15.2% | 0.04% | -21.7% |
| Q4 2019 | $46,081,000 | +4.7% | 790,678 | +7.9% | 0.05% | 0.0% |
| Q3 2019 | $44,012,000 | -4.3% | 732,684 | -11.0% | 0.05% | 0.0% |
| Q2 2019 | $45,975,000 | +4.2% | 823,186 | +4.0% | 0.05% | +4.5% |
| Q1 2019 | $44,108,000 | +13.7% | 791,604 | -7.9% | 0.04% | +2.3% |
| Q4 2018 | $38,783,000 | -41.8% | 859,937 | -15.0% | 0.04% | -29.5% |
| Q3 2018 | $66,625,000 | +1.9% | 1,011,455 | -0.3% | 0.06% | -4.7% |
| Q2 2018 | $65,357,000 | +2.1% | 1,014,702 | -12.2% | 0.06% | 0.0% |
| Q1 2018 | $63,992,000 | +31.6% | 1,156,350 | +13.8% | 0.06% | +33.3% |
| Q4 2017 | $48,640,000 | -6.9% | 1,016,305 | -1.8% | 0.05% | -9.4% |
| Q3 2017 | $52,232,000 | +37.3% | 1,034,702 | +48.3% | 0.05% | +32.5% |
| Q2 2017 | $38,036,000 | +45.3% | 697,772 | +12.3% | 0.04% | +42.9% |
| Q1 2017 | $26,172,000 | – | 621,224 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
| Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
| Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
| KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
| Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
| Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
| Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
| COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |